Mark Kawakami, the Chief Financial Officer of Arcadia Biosciences , Inc. (NASDAQ:RKDA), recently acquired 700 shares of the company's common stock. The purchase, made on February 3, was valued at ...
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 11.21% ...